AMED
Income statement / Annual
Last year (2024), Amedisys, Inc.'s total revenue was $2.35 B,
an increase of 5.01% from the previous year.
In 2024, Amedisys, Inc.'s net income was $43.23 M.
See Amedisys, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$2.35 B |
$2.24 B |
$2.22 B |
$2.21 B |
$2.07 B |
$1.96 B |
$1.66 B |
$1.53 B |
$1.44 B |
$1.28 B |
| Cost of Revenue |
$1.33 B
|
$1.25 B
|
$1.26 B
|
$1.23 B
|
$1.19 B
|
$1.15 B
|
$992.86 M
|
$900.73 M
|
$833.06 M
|
$725.92 M
|
| Gross Profit |
$1.02 B
|
$990.87 M
|
$962.77 M
|
$980.76 M
|
$886.15 M
|
$805.30 M
|
$669.72 M
|
$632.95 M
|
$604.40 M
|
$554.63 M
|
| Gross Profit Ratio |
0.43
|
0.44
|
0.43
|
0.44
|
0.43
|
0.41
|
0.4
|
0.41
|
0.42
|
0.43
|
| Research and Development Expenses |
$0.00
|
$3.80 M
|
$3.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$790.11 M
|
$264.01 M
|
$754.06 M
|
$711.24 M
|
$668.30 M
|
$607.93 M
|
$501.31 M
|
$482.21 M
|
$503.43 M
|
$452.44 M
|
| Selling & Marketing Expenses |
$0.00
|
$516.05 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$790.11 M
|
$780.06 M
|
$754.06 M
|
$711.24 M
|
$668.30 M
|
$607.93 M
|
$501.31 M
|
$482.21 M
|
$503.43 M
|
$452.44 M
|
| Other Expenses |
$133.03 M
|
$50.62 M
|
$24.94 M
|
$17.60 M
|
-$5.57 M
|
$18.43 M
|
$3.24 M
|
$3.77 M
|
$3.73 M
|
$9.75 M
|
| Operating Expenses |
$923.14 M
|
$834.48 M
|
$778.99 M
|
$728.84 M
|
$662.73 M
|
$626.35 M
|
$514.57 M
|
$524.40 M
|
$542.63 M
|
$486.52 M
|
| Cost And Expenses |
$2.25 B
|
$2.08 B
|
$2.04 B
|
$1.96 B
|
$1.85 B
|
$1.78 B
|
$1.51 B
|
$1.43 B
|
$1.38 B
|
$1.21 B
|
| Interest Income |
$8.11 M
|
$3.27 M
|
$178,000.00
|
$49,000.00
|
$292,000.00
|
$78,000.00
|
$278,000.00
|
$158,000.00
|
$75,000.00
|
$71,000.00
|
| Interest Expense |
$30.76 M
|
$31.27 M
|
$22.23 M
|
$9.53 M
|
$11.04 M
|
$14.52 M
|
$7.37 M
|
$5.03 M
|
$5.16 M
|
$10.78 M
|
| Depreciation & Amortization |
$18.00 M
|
$23.85 M
|
$24.94 M
|
$30.90 M
|
$28.80 M
|
$18.43 M
|
$13.26 M
|
$17.12 M
|
$19.68 M
|
$20.04 M
|
| EBITDA |
$73.45 M |
$216.91 M |
$207.41 M |
$320.66 M |
$250.66 M |
$203.35 M |
$179.62 M |
$128.28 M |
$81.45 M |
$88.14 M |
| EBITDA Ratio |
0.03
|
0.1
|
0.12
|
0.15
|
0.14
|
0.12
|
0.11
|
0.09
|
0.06
|
0.08
|
| Operating Income Ratio |
0.04
|
0.07
|
0.08
|
0.11
|
0.11
|
0.09
|
0.09
|
0.05
|
0.04
|
-0.01
|
| Total Other Income/Expenses Net |
-$8.32 M
|
-$116.77 M
|
-$20.53 M
|
$28.32 M
|
-$8.45 M
|
-$7.06 M
|
$3.84 M
|
$2.28 M
|
$4.23 M
|
$8.86 M
|
| Income Before Tax |
$86.22 M
|
$39.62 M
|
$160.24 M
|
$280.23 M
|
$210.82 M
|
$170.41 M
|
$158.99 M
|
$80.80 M
|
$61.57 M
|
-$308,000.00
|
| Income Before Tax Ratio |
0.04
|
0.02
|
0.07
|
0.13
|
0.1
|
0.09
|
0.1
|
0.05
|
0.04
|
-0
|
| Income Tax Expense |
$48.05 M
|
$50.56 M
|
$42.55 M
|
$70.07 M
|
$25.64 M
|
$42.50 M
|
$38.86 M
|
$50.12 M
|
$23.94 M
|
$2.00 M
|
| Net Income |
$43.23 M
|
-$9.75 M
|
$118.61 M
|
$209.07 M
|
$183.61 M
|
$126.83 M
|
$119.35 M
|
$30.30 M
|
$37.26 M
|
-$3.02 M
|
| Net Income Ratio |
0.02
|
-0
|
0.05
|
0.09
|
0.09
|
0.06
|
0.07
|
0.02
|
0.03
|
-0
|
| EPS |
1.32 |
-0.3 |
3.65 |
6.41 |
5.64 |
3.95 |
3.64 |
0.9 |
1.12 |
-0.0915 |
| EPS Diluted |
1.31 |
-0.3 |
3.63 |
6.34 |
5.52 |
3.84 |
3.55 |
0.88 |
1.1 |
-0.0915 |
| Weighted Average Shares Out |
$32.72 M
|
$32.49 M
|
$32.52 M
|
$32.64 M
|
$32.56 M
|
$32.14 M
|
$32.79 M
|
$33.70 M
|
$33.20 M
|
$33.02 M
|
| Weighted Average Shares Out Diluted |
$33.05 M
|
$32.60 M
|
$32.65 M
|
$32.97 M
|
$33.27 M
|
$32.99 M
|
$33.61 M
|
$34.30 M
|
$33.74 M
|
$33.02 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
